Key Cancer Glycosylation-related Genes Analysis: Regulatory, Therapeutic, and Prognostic Insights

Yida Wang,Xuanming Chen,Xiangyu Jin,Jinku Bao

DOI: https://doi.org/10.21203/rs.3.rs-4935472/v1

2024-01-01

Abstract:Background: Glycosylation, a key post-translational modification, involves glycosylation-related genes (GRGs) that are crucial in cancer development. Despite their significance, the roles of GRGs in cancer pathways remain insufficiently understood. This study aims to elucidate the function of GRGs across different cancer types, assessing their potential impact on treatment and prognosis. Methods: We conducted an extensive analysis of over 9,000 samples spanning 33 cancer types, focusing on genomic alterations, cluster analysis, pathway correlations, tumor immunity, miRNA interactions, and identification of therapeutic agents targeting GRGs. Results: Our genomic landscape analysis identified significant events such as the amplification of B4GALT1 and POMGNT1, co-mutations of POMGNT1-GALNT3-FUT3, and co-amplifications of POMGNT1-B4GALT2. Cluster analysis based on GRG expression revealed four distinct cancer subtypes. Pathway analysis demonstrated a positive correlation between GRGs and both E2F_TARGET and p53_PATHWAY. Additionally, GRGs were involved in tumor immunity and predicted responses to PD-1 blockade therapy. A network of miRNA-GRG interactions was uncovered, and GRG expression was predictive of patient survival across 21 cancer types. We also identified potential therapeutic agents targeting key GRGs. Conclusions: This comprehensive analysis of GRGs provides critical insights into their roles in cancer development, prognosis, and therapy, offering a robust foundation for future functional and therapeutic studies in oncology.